Expertise in
2
conditions

Dr. Theodore L. Deweese

Radiation Oncology
600 N Wolfe St, 
Baltimore, MD 
Accepting New Patients
Expertise in
2
conditions
600 N Wolfe St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Theodore Deweese is a Radiation Oncologist in Baltimore, Maryland. Dr. Deweese is highly rated in 2 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy. Dr. Deweese is currently accepting new patients.

His clinical research consists of co-authoring 145 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

600 N Wolfe St, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Biological
Study Drugs: Aglatimagene besadenovec, Valacyclovir
Study Phase: Phase 3
Non-invasive Detection of Cancer DNA in Blood and Urine
Non-invasive Detection of Cancer DNA in Blood and Urine
Enrollment Status: Active_not_recruiting
Publish Date: July 04, 2025
Intervention Type: Procedure
Evaluation of PSMA-based PET as an Imaging Biomarker of Androgen Receptor Signaling in High-Risk Localized and Locally Advanced Prostate Cancer
Evaluation of PSMA-based PET as an Imaging Biomarker of Androgen Receptor Signaling in High-Risk Localized and Locally Advanced Prostate Cancer
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: DCFPyL
Study Phase: Early Phase 1
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2025
Intervention Type: Other, Drug
Study Drug: Flutamide
Study Phase: Early Phase 1
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
Enrollment Status: Active_not_recruiting
Publish Date: November 04, 2024
Intervention Type: Drug, Radiation
Study Drug: Radium-223
Study Phase: Phase 2
Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
Enrollment Status: Active_not_recruiting
Publish Date: June 07, 2024
Intervention Type: Drug, Radiation
Study Drug: Androgen deprivation therapy 
Study Phase: Phase 1/Phase 2
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2
Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy
Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy
Enrollment Status: Unknown
Publish Date: May 31, 2023
Intervention Type: Drug, Radiation
Study Drug: Enzalutamide
Study Phase: Phase 2
View 7 Less Clinical Trials

145 Total Publications

Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer.
Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Lawrence R. Kleinberg
Radiation Oncology
Expertise in
28
conditions
Dr. Lawrence R. Kleinberg
Radiation Oncology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lawrence Kleinberg is a Radiation Oncologist in Baltimore, Maryland. Dr. Kleinberg is highly rated in 28 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery. Dr. Kleinberg is currently accepting new patients.

Expertise in
18
conditions
Dr. Russell K. Hales
Radiation Oncology
Expertise in
18
conditions
Dr. Russell K. Hales
Radiation Oncology

Johns Hopkins University

301 Mason Lord Dr, Suite 1201, 
Baltimore, MD 
 (2.5 miles away)
410-550-2339
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Russell Hales is a Radiation Oncologist in Baltimore, Maryland. Dr. Hales is highly rated in 18 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Thymic Epithelial Tumor, Non-Small Cell Lung Cancer (NSCLC), and Endoscopy. Dr. Hales is currently accepting new patients.

Expertise in
6
conditions
Dr. Phuoc T. Tran
Radiation Oncology
Expertise in
6
conditions
Dr. Phuoc T. Tran
Radiation Oncology

Maryland Proton Treatment Center, LLC

850 W Baltimore St, 
Baltimore, MD 
 (2.2 miles away)
410-227-7434
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Phuoc Tran is a Radiation Oncologist in Baltimore, Maryland. Dr. Tran is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Prostatectomy, and Pancreaticoduodenectomy. Dr. Tran is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Deweese's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile